Veronika Skvortsova, who leads the Federal Medical and Biological Agency, spoke about a rising trend in neurological disorders following COVID-19 infections. The remarks were shared during a public event and reported by DEA News. According to her, the most frequently observed neurological symptoms after a coronavirus infection include extreme fatigue or asthenia, motor impairments such as cerebral palsy-like weakness, and persistent headaches. These findings reflect a pattern seen across clinical settings where post-viral effects linger well after the acute illness, underscoring the need for long-term monitoring and rehabilitation pathways for those recovering from COVID-19.
Skvortsova explained that a severe infection can trigger inflammatory responses, disturbances in blood coagulation, and damage to the microvascular network. The combination of these factors often leads to concurrent COVID-19 outcomes and vascular events, including strokes. This connection has been discussed in various forums, including remarks made on the sidelines of SPIEF, highlighting the importance of early identification of neurologic symptoms in patients who have had COVID-19 and the necessity for integrated care that addresses both infectious and cerebrovascular risks.
In addition to neurological concerns, Skvortsova addressed vaccine-related observations. She described a Russian coronavirus vaccine as showing broad effectiveness across multiple strains, including variants such as Convasel and omicron and its subtypes. The explanation noted that the so-called omicron-latent form is distinguished by a set of mutations that set it apart from other strains. While the aim of this assertion was to emphasize cross-strain protection, it also reflected ongoing discussions about how vaccines perform against evolving coronavirus variants and the importance of continued vaccine development and surveillance to maintain broad immunity across populations. ”